Ligand (LGND) Company Sales Revenue

Corporate emblem and logo of ligand.com (LGND)

Annual sales volume for Ligand Pharmaceuticals (LGND) demonstrates revenue dynamics, where 0.25 shows the current value of the metric. Management is masterfully assembling a licensing portfolio, reducing R&D costs through a royalty model. Management effectively selects promising molecules, ensuring a return on capital. Meanwhile, partner capacities operate stably, and in-house laboratories are regularly updated, eliminating any research downtime.

LGND - Ligand Pharmaceuticals Revenue and Sales Volume over the range 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Ligand Pharmaceuticals Incorporated (LGND)

- market price and analyst price targets:
Comprehensive company analysis:Ligand Pharmaceuticals LGND
Mass-produced product of Ligand

The effectiveness of Ligand Pharmaceuticals (LGND) partnerships with global pharma behemoths converts directly into a daily revenue stream from the joint commercialization of drugs. This metric captures the actual volume of incoming cash flows, allowing investors to assess the gap between operational results and market expectations through changes in the company's sales volume, which is critical for avoiding overpaying for the asset.

Key competitors

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Revenue and Sales Volume Amneal Corp AMRX|Perrigo Company PLC - Revenue and Sales Volume|ALVO: Company Revenue|liquidia.com (LQDA) - Company Revenue|GLPG (Galapagos) - Company Revenue|Company Sales ANIP|Company Sales Volume MNKD (Afrezza)|Revenue and Sales Volume AMPH|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP